NCT05354427View on ClinicalTrials.gov

Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients

CompletedOBSERVATIONAL
Enrollment

175

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

January 1, 2022

Study Completion Date

January 1, 2022

Conditions
Prostate Cancer
Interventions
OTHER

Observation

Assessment of rectal dosimetry change from pre-insertion to post-insertion in subjects with prostate cancer who have undergone radiotherapy with implantabale spacers.

Trial Locations (2)

Unknown

Institute of Maria Skłodowska, Curie (MCMCC), Warsaw

Cuf Porto institution, Porto

Sponsors

Lead Sponsor

BioProtect
All Listed Sponsors
lead

BioProtect

INDUSTRY